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Endoplasmic reticulum (ER) stress signaling can be mediated by the ER kinase PERK, which phosphorylates its substrate eIF2a.
This in turn, results in translational repression and the activation of downstream programs that can limit cell growth through
cell cycle arrest and/or apoptosis. These responses can also be initiated by perturbations in cell adhesion. Thus, we
hypothesized that adhesion-dependent regulation of PERK signaling might determine cell fate. We tested this hypothesis in
a model of mammary acini development, a morphogenetic process regulated in part by adhesion signaling. Here we report
a novel role for PERK in limiting MCF10A mammary epithelial cell proliferation during acinar morphogenesis in 3D Matrigel
culture as well as in preventing mammary tumor formation in vivo. We show that loss of adhesion to a suitable substratum
induces PERK-dependent phosphorylation of eIF2a and selective upregulation of ATF4 and GADD153. Further, inhibition of
endogenous PERK signaling during acinar morphogenesis, using two dominant-negative PERK mutants (PERK-DC or PERK-
K618A), does not affect apoptosis but results instead in hyper-proliferative and enlarged lumen-filled acini, devoid of proper
architecture. This phenotype correlated with an adhesion-dependent increase in translation initiation, Ki67 staining and
upregulation of Laminin-5, ErbB1 and ErbB2 expression. More importantly, the MCF10A cells expressing PERKDC, but not
a vector control, were tumorigenic in vivo upon orthotopic implantation in denuded mouse mammary fat pads. Our results
reveal that the PERK pathway is responsive to adhesion-regulated signals and that it is essential for proper acinar
morphogenesis and in preventing mammary tumor formation. The possibility that deficiencies in PERK signaling could lead to
hyperproliferation of the mammary epithelium and increase the likelihood of tumor formation, is of significance to the
understanding of breast cancer.
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INTRODUCTION
Adhesion signaling is critical during mammary gland development
where precise regulation of apoptosis and proliferation leads to
proper tissue architecture and function [1]. For example, apoptosis
of cells that detach from the basement membrane is required for
the formation of the luminal space and overexpression of agonist-
regulated dimerizing ErbB2 receptors disrupts this process and
leads to multi-acinar structures devoid of a hollow lumen [2]. In
addition, a distinguishing feature of breast cancers is the
delocalized cell proliferation that leads to filling of the ductal
lumen (i.e. DCIS) or complete loss of tissue architecture as
observed in invasive carcinomas [3,4]. Studies using a 3D in vitro
MCF10A model of mammary acinar morphogenesis [4], as well as
2D adhesion vs. suspension growth assays revealed that loss of
adhesion and lumen formation requires anoikis, a process that
activates classical apoptotic mediators such as Bim [5–7].
However, other pathways may be activated to ensure proper
lumen formation and their deregulation might lead to aberrant
acinar development and subsequent tumor formation.
Early studies by Benecke et al., [8,9] showed that fibroblasts that
are denied attachment greatly repress translation initiation. This
response can also lead to cellular quiescence [10,11]. However, the
mechanisms behind these responses were unknown. Translation
initiation can be repressed by the 4EBP-dependent inhibition of
the CAP-binding protein eIF4E or through the phosphorylation of
the translation initiation factor eIF2a [12]. The latter is a target of
kinases activated by different stimuli. For example, PKR or GCN2
can phosphorylate eIF2a in response to dsRNA or nutrient
deprivation, respectively [13]. The endoplasmic reticulum (ER)
kinase PERK can also phosphorylate eIF2a and repress translation
initiation during stress conditions caused by unfolding of proteins
[14]. PERK can induce growth arrest and/or apoptosis and has
been linked to the induction of genes such as the transcription
factor GADD153/CHOP [15,16] or inhibition of cyclin D1
[17,18]. Interestingly, ER stress signaling has been shown to be
a negative regulator of malignancy in human squamous carcinoma
cells [19,20] and of H-Ras-mediated transformation of human
melanocytes [21]. Further, inhibition of PKR and subsequent
reduced phosphorylation of eIF2a was sufficient to cause trans-
formation of mouse NIH3T3 fibroblasts [22]. These results suggest
that phosphorylation of eIF2a could potentially have a tumor
inhibitory function.
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role of adhesion signaling during mammary acini lumen formation
and filling [2,23,24] [3]. Interestingly, ATF4 and GADD153 (a
target of ATF4) [25], two genes selectively upregulated by PERK
signaling, are upregulated at different stages during mammary
gland development [26,27], suggesting that this pathway may be
naturally regulated in this tissue. Further, loss of adhesion can
strongly attenuate translation, a critical function of PERK [28],
and signals that circumvent anoikis and stimulate proliferation can
lead to lumen filling [29]. Thus, we hypothesized that adhesion-
dependent regulation of PERK-eIF2a signaling for cell death and/
or growth arrest may be important for acinar development and
prevent aberrant growth. Given that PERK-eIF2a signaling can
result in inhibition of proliferation or induction of apoptosis we
explored these two possibilities as functional outputs of this
pathway in vitro and in vivo.
RESULTS
It is known that loss of adhesion results in anoikis of epithelial cells
[6] and this has been observed during in vitro acinar development
[4]. Further, suspension growth assays have been very useful in
elucidating the mechanistic intricacies linked to anoikis and acinar
lumen formation in MCF10A cells [30]. Thus, we first used this
standardized assay of adhesion vs. suspension growth, in order to
gain insight into the link between the regulation of eIF2a
phosphorylation and adhesion signaling.
Adhesion Regulates The Phosphorylation of eIF2a
and Protein Synthesis In MCF10A Cells
We first determined whether the loss of adhesion might activate
eIF2a phosphorylation at Ser51 (P-eIF2a), and if this response
correlated with the growth arrest and apoptosis of MCF10A cells
in suspension. MCF10A cells were detached by mild trypsinization
or with PBS/2mM EDTA and after neutralization with media
containing 5% horse serum, cells were either replated on tissue
culture dishes (adhered conditions) or on dishes coated with agar
in media containing 0.5% methylcellulose [30] for 24–48 hrs
(suspension conditions) (Fig 1A). Western blots revealed that at
24 hrs in suspension there was increased phosphorylation of eIF2a
at Ser51 (Fig 1A), which was detectable as early as 4 hrs in
suspension (data not shown) and comparable to the signal induced
by 2mM DTT treatment [31]. The time course of eIF2a
phosphorylation in suspension correlated with the timing of
withdrawal from S-phase and the subsequent onset of apoptosis in
the same cells placed in suspension (Fig 1B). Primary human
mammary epithelial cells (HMECs) and human kidney epithelial
cells (HEK293T) also displayed increased levels of phosphorylated
eIF2a when placed in suspension, suggesting that this is
a conserved response in normal and immortalized epithelial cells
(Fig 1A). We next tested whether phosphorylation of eIF2a
correlated with inhibition of protein synthesis in MCF10A cells.
Growth in suspension caused a robust attenuation of general
protein synthesis as measured by
35S-Met incorporation (Fig 1C).
This effect was comparable to the inhibition caused by 2mM DTT
treatment and appeared as early as 4 hrs in suspension (data not
shown). Similarly, relative to adhered cells, suspension conditions
showed a significant decrease in the polysomes and a correspond-
ing increase in the monosome peak (i.e. single 80s subunits)
(Fig 1D). We conclude that suspension-induced eIF2a phosphor-
ylation is associated with inhibition of translation initiation and
this response correlates with an initial growth arrest followed by
apoptosis of MCF10A cells.
Induction of ATF4 and GADD153 in Suspension Is
Not Accompanied by Chaperone Upregulation
Concomitant to general translation repression, phosphorylation of
eIF2a results in preferential translation of the ER stress regulated
transcription factor ATF4 while the mRNA levels remain constant
[25]. We therefore determined whether accumulation of ATF4
protein occurred in the absence of an increase in mRNA levels in
adhered vs. suspension conditions. MCF10A cells grown adhered
or in suspension for 24 hrs showed no increase in the levels of
ATF4 mRNA (Fig 2A). In contrast, detection of ATF4 protein by
Western blot showed a strong increase in ATF4 protein levels at
24 and 48 hrs (Fig 2A) in suspended MCF10A and HMEC cells,
suggesting a translational enhancement of ATF4 message. This
was confirmed with experiments showing that the ATF4 mRNA
was preferentially enriched in heavy polysome fractions only in
MCF10A cells kept in suspension (data not shown). We further
tested whether cells in suspension showed ATF4 protein
accumulation as measured by IF. These results (Fig 2C) show
that as early as 4 hrs and as late as 24 and 48 hrs post-suspension,
ATF4 protein expression increased and displayed a nuclear
localization pattern. Thapsigargin treatment used as a positive
control also increased ATF4 expression and nuclear localization.
An anti-HA rabbit polyclonal Ab used as a negative control
showed no staining (data not shown). Together these results
strongly suggest that loss of anchorage of normally adherent cells
initiates stress signals that result in eIF2a phosphorylation and
subsequent upregulation of ATF4 protein expression.
We next determined whether integrins were required to regulate
eIF2a phosphorylation. To this end we used a b1-integrin
function-blocking monoclonal antibody (AIIB2) previously shown
to disrupt cell adhesion [24]. MCF10A cells were pre-incubated in
suspension with 10 mg/ml AIIB2 antibody (Fig 2B) for 30 min at
37uC and then allowed to adhere to various matrices including
10 mg/ml Laminin-1 (LN-1). We found that while a control IgG
had no effect on adhesion to LN-1 (Fig 2D) or Matrigel (data not
shown), treatment with the AIIB2 antibody resulted in almost
complete cell rounding and detachment accompanied by an
increase in phosphorylation of eIF2a and upregulation of ATF4
(Fig 2B and 2D). These results further strengthen our hypothesis
that adhesion signals mediated by ligand-bound integrins are
required to maintain eIF2a phosphorylation at basal levels.
We next determined whether the growth-arrest and DNA-
damage 153 (GADD153) gene [15,32] [33], an ATF4 target, was
upregulated in suspension [34]. MCF10A cells placed in
suspension showed increases in GADD153 mRNA as early as
6 hrs and a strong upregulation of the mRNA and protein were
also detected at 24 hrs (Fig 3A and C). IF studies revealed
a similar increase that was quantitated by FACS (Fig 3D and E).
We also detected a 6-fold upregulation of GADD153 promoter
activation measured using a GADD153 promoter-driven EGFP
reporter construct and flow cytometry (Fig 3B). In HEK293T
cells both GADD153-EGFP reporter activity and endogenous
GADD153 mRNA were increased after cells were placed in
suspension for 24 hrs (Fig 3A and3F). Interestingly, in both
MCF10A and HEK293T cells, GADD153-EGFP reporter activity
was downregulated by overexpression of GADD34, a regulatory
subunit of the phosphatase PP1C that dephosphorylates eIF2a
[35], suggesting a dependence on eIF2a phosphorylation (Fig 3F).
We also detected a weak increase in XBP-1 splicing [36] in
suspension (Fig 3G upper panel), which was followed by
a marginal increase in protein levels (data not shown). However, in
contrast to ATF4 and GADD153, this increase was only
detectable at 24 hrs and not comparable to that induced by
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PLoS ONE | www.plosone.org 2 July 2007 | Issue 7 | e6152mM DTT treatment. This suggests that XBP-1 splicing may not
be a major pathway activated by suspension growth conditions or
that it may be activated later, when the vast majority of the cells
are committed to apoptosis. Unlike GADD153 expression, no
significant changes were observed in suspension for the expression
of canonical ER stress-induced response genes such as the
chaperones, BiP/Grp78, Hsp47 or PDI/Erp72 (Fig 3G, lower
panels) [37]. The lack of upregulation of these markers suggests
that while suspension growth assays induce eIF2a phosphoryla-
tion, ATF4 and GADD153 expression and to a lesser extent XBP-
1 splicing, these changes do not immediately impact the expression
of some UPR-regulated chaperones.
Suspension-Induced Phosphorylation of eIF2a at
Ser-51 Involves PERK Activation
The above results were intriguing because they suggested that
changes in adhesion might regulate ER kinases or other signaling
pathways that result in phosphorylation of eIF2a. Thus, we next
determined whether GCN2, PKR or PERK were kinases
potentially responsible for the increase in eIF2a phosphorylation
in suspension. While total GCN2 protein levels were abundant
and slightly higher in adhered vs. suspension conditions at 48 hrs
(GAPDH shows equal loading), we found very low levels of
phospho-GCN2 that were not modulated by suspension at these
Figure 1. Suspension Induces Phosphorylation of eIF2a and Translation Repression in Mammary and Kidney Epithelial Cells. (A) Whole cell
lysates from MCF10A (upper left), HEK293T (upper right) and primary HMEC (lower panels) cells grown either in adhered (A) or suspended conditions
(S) as described in the methods section for the indicated time points, were immunoblotted for p-eIF2a and total eIF2a levels. Adhered MCF10A or
HEK293T cells treated with 2 mM DTT or 5 mg/ml tunicamycin (Tn) respectively, were used as positive controls. (B) Quantification of the rate of DNA
synthesis using a BrdU incorporation assay and flow cytometry to measure the percentage of BrdU-positive cells (filled diamonds) at different time
points in suspension. The percentage of apoptotic cells was measured using propidium iodide staining and flow cytometry to identify the sub-G0
apoptotic fraction for adhered (dashed line) or suspended (dotted line) MCF10A cells for different time points. Data points show the mean6SD for
BrdU–positive cells in each sample as a percentage of the total. (C) Autoradiogram of [
35S] Met/Cys incorporation (right panel) into newly synthesized
proteins in MCF10A cells adhered or suspended for 24 hrs (two independent samples). Coomassie Blue staining of an identical gel (left panel) shows
equal protein loading. (D) Polysome profiles from 24 hr adhered (left) and suspended (right) MCF10A cells showing an increase and decrease in the
monosome and polysome peaks, respectively in suspended cells. Absorbance at 254 nm (Y-axis, RNA concentration) was plotted against migration in
the sucrose gradient (X-axis, bottom to top). Total RNA was isolated from individual fractions to visualize the 18S and 28S rRNAs by ethidium bromide
staining.
doi:10.1371/journal.pone.0000615.g001
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PLoS ONE | www.plosone.org 3 July 2007 | Issue 7 | e615Figure 2. ATF4 Protein Levels Are Strongly Upregulated During Suspension Conditions. (A) RT-PCR analysis of ATF4 or GAPDH (as loading control)
mRNA levels, in adhered (A) or suspended (S) MCF10A cells, (left panels); ATF4 protein levels or GAPDH (as loading control) in MCF10A (right panels)
and primary HMEC cells (bottom panels) as detected by Western blotting. (B) Immunoblot showing increased levels of p-eIF2a (upper panels) or ATF4
(lower panels) protein comparable to that induced by suspension, in MCF10A cells pretreated with AIIB2, a b1-integrin function-blocking Ab (10 mg/
ml). Control cells were treated with an isotype-matched IgG (10 mg/ml). Total eIF2a was used as loading control. (C) Immunofluorescent staining for
ATF4 (red) in MCF10A cells immediately after detachment (0 hrs) and placed in suspension for the indicated time points or treated with thapsigargin
(4 mM) for 6 hrs before fixing on poly-lysine-coated coverslips to facilitate detection. (D) Photomicrographs of MCF10A cells plated on Laminin-1
coated tissue culture dishes, pre-incubated with AIIB2 (10 mg/ml) or a control IgG antibody (10 mg/ml) prior to plating or placed in suspension on
agar-coated dishes in the presence of 0.5% methylcellulose in media containing 1% serum.
doi:10.1371/journal.pone.0000615.g002
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control. Similarly, suspension growth conditions did not significantly
affect phospho- or total-PKR levels (Fig 4B). The expression of
another eIF2a kinase, the heme-regulated initiation factor 2a kinase
(HRI) is mostly restricted to cells of the hematopoietic lineage [38].
Thus, we focused on PERK as a potential transducer of suspension-
induced eIF2a phosphorylation.
To test the link between adhesion and PERK signaling we
determined whether WT or PERK-/-MEFs [14] displayed
differential phosphorylation of eIF2a in suspension. As shown in
Fig 4C, WT-MEFs placed in suspension for 24 hrs showed
a robust phosphorylation of eIF2a at Ser51. Strikingly, this
response was greatly reduced in PERK-/-MEFs, suggesting that
PERK is an important contributor to eIF2a phosphorylation in
response to cell detachment in mouse cells (Fig 4C). We next
tested PERK phosphorylation in MCF10A cells. Our results in
Fig 4D show that after 24 hrs in suspension there is a strong
phosphorylation of PERK, while almost no signal can be detected
in adhered conditions for the same time. This correlates with the
robust phosphorylation of eIF2a shown in Fig 1A and 2B. Total
PERK levels appeared unchanged in adhered vs. suspension
conditions. A slightly slower mobility of PERK protein in
Figure 3. GADD153 mRNA and Protein Levels Are Strongly Upregulated During Suspension Conditions. (A) RT-PCR analysis of GADD153 mRNA
levels in MCF10A (left panel) and HEK293T (right panel) cells at different time points in either adhered (A) or suspended (S) conditions. Adhered
MCF10A cells treated with 2mM DTT for 4h were used as positive control and GAPDH was used as a loading control. (B) MCF10A cells were transiently
transfected with a GADD153 promoter-driven-EGFP reporter plasmid and EGFP fluorescence was analyzed 48 h post-transfection by FACS; total
events captured: 2610
4. The graph shows the number of GFP-positive events in FLH2.10 (mean6SD). (C) Western blot for GADD153 protein in
adhered (A) or suspended (S) MCF10A cells. (D and E) Immunofluorescence (D) and FACS (E) analysis of GADD153 (red) expression in MCF10A cells
following growth in adhered or suspension conditions for the indicated times. Secondary antibody was used as negative control in E. (F) MCF10A
(top) and HEK293T (lower) cells were transiently co-transfected with the GADD153-EGFP reporter plasmid and either a full-length Flag-tagged
GADD34 plasmid or an empty vector as control for 24 hrs before being detached and left to reattach or put into suspension for an additional 48 hrs
before FACS analysis. GFP fluorescence was analyzed 48 h post transfection by FACS where a total 2610
4 events were captured. The graphs show the
number of GFP positive events in FLH2.10 or the mean fluorescence intensity (MFI) in the PMT2-FITC channel (mean6SD). (G) RT-PCR for XBP-1
splicing (top panel) in MCF10A cells at different time points either adhered (A) or suspended (S). Adhered MCF10A cells treated with 2mM DTT for
4 hrs was used as positive control and GAPDH, shown in (A) was used as a loading control. Lower panels show RT-PCR for BiP, Hsp47 and Erp72/PDI
chaperone mRNA levels in adhered (Adh) or suspended (Sus) MCF10A cells. GAPDH was used as a loading control.
doi:10.1371/journal.pone.0000615.g003
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is the fact that our attempts to reliably detect any endogenous
phospho-PERK levels in HEK293T cells by Western blotting were
unsuccessful even in the presence of ER stressors such as DTT,
tunicamycin or thapsigargin. Thus, to further support that PERK
activation can be detected in these epithelial cells in suspension
and that this correlates with the increase in P-eIF2a, we relied on
the detection of overexpressed PERK. To this end, HEK293T
cells, which display eIF2a phosphorylation in suspension (Fig 1A)
were transfected (,100% transfection efficiency) with a mouse
myc-tagged wtPERK for 48 hrs and then placed in adhered vs.
suspension conditions for 24 hrs. As mentioned above, vector
transfected cells showed no detectable P-PERK signals (Fig 4E).
In contrast, adhered HEK293T cells expressing wtPERK
displayed detectable PERK phosphorylation that, unlike GCN2
and PKR, was strongly increased in suspension (Fig 4E). To
functionally test the role of PERK signaling in MCF10A cells we
used genetic approaches to target this pathway. We retrovirally
transduced these cells to stably express a pBabe-puro construct
encoding a Myc-tagged dominant negative PERK where the C-
terminal cytoplasmic kinase domain is deleted (PERKDC) (Fig 4F–
G) or a mutant where Lys-618 was mutated to Ala, which results
in a kinase dead (PERK-K618A) enzyme (Fig 4H–I). Control
MCF10A cells were transduced with a virus encoding pBabe-puro
plasmid encoding b-galactosidase as vector control. In all
experiments P-eIF2a, ATF4 (Fig 4G,H,I) and GADD153
(Fig 4I) were used as a read-out of PERK activity. Expression
of the dominant negative PERKDC resulted in inhibition of the
increase in P-eIF2a, ATF4 in suspension (Fig 4G) without
significantly affecting total eIF2a levels. GAPDH was used as
Figure 4. PERK is the Major Upstream Kinase Mediating Phosphorylation of eIF2a in Suspension. (A and B) Immunoblot for phospho- and total
GCN2 and PKR in MCF10A cells in adhered or suspension conditions for 24 and 48 hrs. Note that only a faint phospho-protein band for phospho-
GCN2 was observed at the 220 kD position but in adhered conditions. GAPDH was used to show equal loading. (C) IB for phospho-(top blot) and
total- (bottom blot) eIF2a in PERK wild-type and PERK-/-MEFs grown in adhesion (A) or in suspension (S) for 24 hrs. (D) IB for phospho- and total PERK
in MCF10A cells grown adhered (A) or in suspension (S) for 24 hrs. (E) IB for phospho- PERK and myc in HEK293T cells transiently transfected with
empty vector control or mouse WT-myc tagged-PERK and placed in adhered (A) or suspended (S) conditions for 24 hrs. GAPDH serves as loading
control. (F) IB for Myc-PERKDC expression in parental and in MCF10A cells stably expressing either pBabepuro-myc-PERKDC or a vector control
pBabepuro-b-galactosidase construct. (G) IB for phospho- and total eIF2a and ATF4 expression in b-Gal or myc-PERKDC expressing cells either
adhered or suspended for 24 and 48 hrs. GAPDH was used as loading control. (H) IB for Myc, phospho and total eIF2a and GAPDH in MCF10A cells
stably expressing b-Gal (vector control) or a pBabeneo-PERK-K618A (kinase dead) mutant. (I) Cells obtained in (H) were used in a suspension vs.
adhesion assay for 24 hrs and ATF4 and GADD153 expression was detected through IB in the cell lysates. GAPDH was used as a loading control.
doi:10.1371/journal.pone.0000615.g004
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K618A mutant also inhibited basal eIF2a phosphorylation
(Fig 4H). In addition, suspension-induced ATF4 and GADD153
was inhibited in MCF10A cells expressing PERK-K618A (Fig 4I).
Together, our results demonstrate that the signal that results in
eIF2a phosphorylation and upregulation of downstream targets by
loss of adhesion of MCF10A cells is largely dependent on PERK.
PERK Inhibition Deregulates Mammary Acinar
Development in 3D Matrigel
Our experiments using 2D culture revealed a strong functional
link between adhesion and PERK signaling. We next determined
the functional output of PERK signaling in MCF10A cells using
3D Matrigel cultures, an assay that recapitulates the physiological
context offered by normal tissue architecture and a process in
which adhesion signaling is critical for proper acinar development
[2,23,24,39]. MCF10A cells cultured in 3D Matrigel proliferate
and go on to form well organized polarized acini and cells that
detach from the basement membrane undergo anoikis favoring
lumen formation [39]. In addition, approximately by day 10 of
development these structures reach their size limit [4]. 3D cultured
MCF10A cells were analyzed through immunofluorescence (IF)
and standard or laser scanning confocal microscopy (LSCM).
Control experiments revealed that as reported [4], these cells
formed at day 12 hollow acini that displayed basal deposition of
laminin-5 (LN-5) around the colony, GM130 (a Golgi marker
protein) localized mostly to the luminal region of the acini where
cleaved (active) caspase-3 positive cells were also observed (data
not shown).
MCF10A cells stably expressing b-Gal, PERKDC or PERK-
K618A dominant negative mutants were cultured in 3D Matrigel
as described above. Strikingly, as early as 8 days in 3D culture and
throughout the assay until day 19, we observed that PERKDC
expressing cells formed significantly larger acini that had an
amorphous multi-lobular architecture (Fig 5A). Staining for
epithelial specific antigen (ESA) [40] or E-cadherin showed the
expected baso- or apico-lateral distribution in b-Gal cells,
respectively (Fig 6A–B). In contrast, PERKDC cells appeared to
have lost epithelial organization as the staining for ESA, in
addition to being stronger appeared disorganized and was present
in the outer rim of cells and also in luminal cells (Fig 6A). E-
cadherin was also distributed in an apico-lateral pattern in b-Gal
cells, while in PERKDC cells a disorganized distribution was
observed, which appeared uniform around the cells and sometimes
basal, suggesting an alteration in polarity (Fig 6B). A similar
phenotype to that resulting from PERKDC expression was
observed for PERK-K618A expressing cells that showed larger
acini with irregular architecture (Fig 5A). We next analyzed the
size differences between b-Gal, PERKDC and PERK-K618A
acini by measuring two perpendicular diameters and calculating
the volume of individual acini considering an ellipsoid morphol-
ogy. We observed that the frequency of PERK-mutant acini in
and above the 0.5–1610
24 mm
3 volume ranges was 5-10-fold
higher than the b-Gal control cells (Fig 5B). Our results reveal
that inhibition of PERK during mammary acini development in
3D results in a deregulation of the process leading to larger multi-
acinar structures devoid of normal architecture and with a filled
lumen.
PERK Inhibits Proliferation During Acinar
Morphogenesis
The increase in PERKDC acini size could result from increased
cell division, reduced apoptosis or a combination of both. To test
whether the inhibition of PERK had any effect on the rate of
apoptosis, we stained the acini on day 8 and 19 for cleaved
caspase-3. Our results revealed that on day 8 relative to the b-Gal
control cells PERKDC expressing cells displayed only a marginal
trend towards reduced apoptosis (Fig 5C, top row and 5D).
Similar results were observed at day 19 (data not shown). These
results suggest that PERK is not required for the activation of
caspase-3 and apoptosis during MCF10A acini formation.
We next stained for Ki67 in the acini, as uncontrolled
proliferation not counterbalanced by increased apoptosis could
account for the larger number of cells and acini size. Through IF,
we scored the number of cells per acini that were positive for Ki67
in b-Gal and PERKDC cells on day 8 in Matrigel. These data
revealed that inhibition of PERK signaling through the PERKDC
construct resulted in an ,2.4 fold increase in Ki67 positive
cells per acinus (p,0.001) (Fig 5C bottom row and 5D), than
the b-Gal control acini. Ki67 positive cells in PERKDC acini were
located both in the rim of the colonies and prominently in the
cell-filled lumen (Fig 5C, bottom row and 5D). These results
allow us to conclude that the importance of PERK signaling
during acini formation is in limiting cell proliferation, rather than
apoptosis.
Based on the finding that PERK inhibition does not affect
caspase-3 activation in luminal cells which undergo anoikis, we
predicted that PERK signaling would not affect 2D suspension-
induced apoptosis. In addition, if translational repression is
important for anoikis, then PERK inhibition should not affect
this process. To test this prediction we determined whether PERK
signaling was linked to suspension induced cell cycle exit, apoptosis
and translational repression. As predicted by our 3D morphogen-
esis assays, suspension-induced S-phase withdrawal and sub-
sequent apoptosis were not affected by the expression of PERKDC
(Fig 6C and data not shown). BimEL is a proapoptotic protein
required for acinar lumen formation [41]. Our data showed equal
levels of BimEL upregulation in both b-Gal and PERKDC cells in
suspension (Fig 6D), which appears to be insensitive to the
attenuation of translation or is highly stable. Furthermore,
35S-Met
incorporation assays comparing adhered vs. suspended b-Gal and
PERKDC cells in full serum (5%) revealed that PERK inhibition
under these conditions does not alleviate translational suppression
(Fig 6E). These results suggest that suspension-induced apoptosis
is not dependent on PERK and this is in agreement with the
caspase-3 activation during acinar morphogenesis.
As shown in Fig 5 and reported previously, proliferation is
mostly restricted to the basal compartment of the normal acini.
Thus, it could be assumed that in contrast to b-Gal acini, which do
not increase in size beyond a certain point (60–70 mm after day
10), cells expressing PERKDC may be unable to repress
translation, favoring proliferation in 3D cultures and subsequent
expansion of these structures. To test this prediction we de-
termined whether translation initiation was affected in adherent b-
Gal or PERKDC cells. The 3D assays were performed in low
serum (2% v/v). Thus, we tested whether adhered PERKDC cells
placed in low serum (1% v/v), which has been shown to result in
reduced translation initiation [42], might be capable of enhanced
35S-Met incorporation. Adhered PERKDC cells grown in these
conditions had a higher basal
35S-Met incorporation than b-Gal
cells. Further, in contrast to control cells, PERKDC cells were
partially resistant to DTT-mediated inhibition of translation
(Fig 6F). Together, our 2D and 3D assay results suggest that
under normal growth conditions PERK functions to inhibit
translation initiation in adhered conditions and that this is
associated with reduced proliferation, but not increased apoptosis,
during acini development.
Adhesion Signals Regulate PERK
PLoS ONE | www.plosone.org 7 July 2007 | Issue 7 | e615Further support that activation of PERK can strongly inhibit
acini formation was obtained by activating PERK signaling in
MCF10A cells stably expressing an Fv2E-DNPERK construct
(Fv2E-PERK) [43]. In these cells the Fv2E dimerization domain is
fused to the cytoplasmic kinase domain of PERK [43] and the
kinase activity and translational repression is induced by forcing
dimerization using the divalent compound AP20187, in the
absence of ER stress [43]. Upon treatment with AP20187 (2nM),
adhered Fv2E-PERK expressing cells showed a sustained increase
in eIF2a phosphorylation between 0.5–1 hrs and the signal was
lower but still sustained by AP20187 treatment at 8 hrs (Fig 7A).
This response was not detected in b-Gal control cells (Fig 7A). b-
Gal and Fv2E-PERK expressing cells cultured in 3D Matrigel
were allowed to develop and at day 4, 2nM AP20187 was added
every 12 or 24 hrs. The results showed that two days later,
AP20187 treatment every 24 hrs had no influence on b-Gal acinar
morphogenesis (Fig 7D), but inhibited acini development of Fv2E-
PERK cells (Fig 7B–C). While only 7% of the vehicle (EtOH)
treated cells were at the 2-4-cell stage on day 6 (Fig 7C),
approximately 20% of the Fv2E-PERK cells treated with
AP20187 were still at this stage (Fig 7C). However, except for
,5% of the FV2E-PERK cells that remained as single cells
regardless of the treatment, the rest of the AP20187 treated cells
(75%) were able to escape the treatment and progress into larger
(.8 cells) acini. We also observed at day 6, when apoptosis is not
fully initiated, that Fv2E-PERK acini treated with AP20187 every
24 hrs showed a 10 fold increase in apoptotic cells, as compared to
controls (Fig 7B–C). Apoptosis was further enhanced by treating
the acini every 12 hrs as detected by increased active caspase-3
staining in the majority of cells in the acini (Fig 7E).Apoptosis may
Figure 5. PERK is Required to Maintain Normal Mammary Acini Growth and Morphogenesis through Regulation of Cell Proliferation. (A)
Representative images through the equatorial cross sections of acini from myc-PERKDC, myc-PERK-K618A or b-gal expressing MCF10A cells on Day 8
of culture in 3D Matrigel, using LSCM. Nuclei are stained green using CyQuant dye. Note the increase in acinar size, luminal filling and the multi-
lobular nature of the PERKDC structures as compared to the vector control acini. PERK-K618A expressing acini were also significantly larger and
always showed luminal cells, but were not frequently multi-lobulated. Scale bars=20 mm. (B) Acinar size was measured on different days in Matrigel
for b-Gal and PERKDC or PERK-K618A cells, using SPOT
TM software to measure two perpendicular diameters per acinus and calculate acinar volume
considering an ellipsoid structure; volume for 50–200 acini were quantitated per time point, shown as percentage of total for the given size range,
Mean6SD. (C) Confocal images for b-Gal and PERKDC cells immunostained for cleaved (*) caspase-3 (red, top panels) or Ki-67 (red, bottom panels) on
Day 8 in Matrigel. Acini are outlined with white dotted lines to delineate the normal b-Gal vs. disorganized large PERKDC acini, which shows Ki-67
positively stained cells in the lumen. Scale bars=20 mm. (D) Graphs showing distribution of the percentage of cells per acinus that stained positively
for Ki-67 or cleaved caspase-3 in b-Gal and PERKDC cells on Day 8 in Matrigel; between 50–100 acini were scored and statistical significance was
determined by the t test for independent samples with P,0.001 defined as statistically significant. #N.S-not significant.
doi:10.1371/journal.pone.0000615.g005
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AP20187 as lower doses induce growth arrest without apoptosis
(data not shown). Together our results strongly support the notion
that PERK is required to limit acini development and that positive
or negative perturbations in PERK signaling can lead to either
blockade or hyper-proliferative acinar morphogenesis, respective-
ly.
PERKDC acini display reduced GADD153 expression
and deregulated Laminin-5 production and
organization
We next tested whether the expression of GADD153 [15,32] and
the levels of laminin-5, a component of the BM of the mammary
acinus [44] were affected by PERK inhibition.
We found that while few cells in control b-Gal acini (Fig 8Ac,e)
displayed GADD153 staining similar to parental MCF10A cells
(Fig 8Aa,b), the aberrant acini formed by MCF10A cells
expressing PERKDC were largely negative for GADD153
expression (Fig 8Ad,f and 8B). The fact that caspase-3 activation
was not inhibited to the same extent by PERKDC, (Fig 5C and
D) suggests that GADD153 induction might be an event
associated with inhibition of proliferation rather than induction
of apoptosis.
The ability of MCF10A cells to deposit basal Laminin-5 (LN-5)
is a characteristic of mammary epithelial cells in vivo and allows for
proper organization and polarity of the basal epithelial layer [29].
The noticeable disorganization in acini architecture caused by
PERK inhibition (Fig 5 and 6) led us to test whether aberrant
deposition of LN-5 might be associated with the ability of cells to
grow in the lumen. b-Gal expressing cells showed an outer rim of
LN-5 staining that clearly delineated the proper basal location of
the BM of the control acini (Fig 9Aa, b and f). However, to our
surprise PERKDC acini showed a much stronger staining for LN-
5( Fig 9Ac, d and e), suggesting increased expression and/or
deposition of LN-5. This suggests a loss of organization since the
Figure 6. Immunofluorescence for ESA and E-cadherin In b-Gal Control and PERKDC Acini. (A) Representative confocal images of cross sections
through b-Gal and PERKDC acini immunostained for the cell surface glycoprotein, ESA (epithelial specific antigen, green), on Day 8 in Matrigel. Note
the presence of ESA in cells occupying the luminal space of PERKDC acini (bottom) as compared to proper basolateral localization of ESA in the b-Gal
control acini (top). (B) Representative confocal images of b-Gal and PERKDC acini co-stained for E-cadherin (green) and Ki-67 (red), on Day 8 in
Matrigel. Note the presence of strong E-cadherin staining in the cell-cell junctions of luminal cells in PERKDC acini that also stain positive for Ki-67
while b-Gal control acini show little to no Ki-67 staining in luminal cells and the expected apicolateral staining for E-cadherin in the outer rim of cells.
Scale bars=10 mm. (C) Proliferation assay using BrdU incorporation and flow cytometry to measure the percentage of BrdU-positive b-Gal or PERKDC
cells at different time points in suspension, mean6SD. (D) Immunoblot showing an increase in BimEL levels in suspension but no significant change
between b-Gal and PERKDC cells, GAPDH serves as loading control. (E) Autoradiogram of [
35S] Met/Cys incorporation into newly synthesized proteins
in b-Gal or PERKDC cells in full (5%) serum media placed in adhered or suspended growth conditions for 8 hrs, 12 hrs or 24 hrs, showing complete
attenuation of protein synthesis in suspension. Coomassie Blue staining of identical gels (left panels) shows protein loading. (F) Autoradiogram of
[
35S] Met/Cys incorporation into newly synthesized proteins in adhered b-Gal or PERKDC cells placed in low (1%) serum media, treated with or
without DTT (2 mM for 1hr), showing increased protein synthesis in PERKDC cells. Coomassie Blue staining of an identical gel (left panel) shows equal
protein loading. Densitometric analysis and surface plotting of the bands illustrates the increase in intensity in the PERKDC cells.
doi:10.1371/journal.pone.0000615.g006
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PLoS ONE | www.plosone.org 9 July 2007 | Issue 7 | e615Figure 7. Unscheduled Activation of PERK Restricts Acinar Growth and Promotes Apoptosis in 3D Matrigel. (A) Time-dependent increase in
phosphorylation of eIF2a in MCF10A cells expressing an Fv2E-DNPERK construct, upon treatment with the dimerizing drug, AP20187 (2 nM). AP20187
has no effect on P-eIF2a levels in b-Gal cells. Total eIF2a was used as loading control. (B) Photomicrographs of Fv2E-DNPERK cells in 3D Matrigel
treated with 2 nM AP20187 or equal volume of ethanol as control, added every 24 hrs from Day 4 up to Day 6 of morphogenesis; representative
phase-contrast images depict the effect of forced PERK activation on acini development; (B-a and B-e) A610 magnification image of several
developing acini; (B-b) Normal acinus, (B-c) 2 cell cluster, (B-f) 4 cell cluster, (B-g) 4 cell cluster containing apoptotic cells. (B-d and h) Confocal images
through the equatorial region of Fv2E-DNPERK cells in 3D Matrigel immunostained for active caspase-3 (red) or LN-5 (green) with (B-h) and without
(B-d) treatment with 2nM AP20187 every 24 hrs, (B-h) cell cluster where the majority of cells have entered apoptosis. (C) Quantitation of phase
contrast images of Fv2E-DNPERK cells on Day 6, treated every 24 hrs with or without 2nM AP20187. Over 400 acini were visually scored for the
presence of apoptotic or growth arrested 2–4 celled acini and calculated as a percentage of the total number of acini; graph shows mean6SD. (D)
Photomicrographs of b-Gal vector control cells treated with 2nM AP20187 or with equal volume EtOH as control, every 24 hrs from Day 4 up to Day 6
in Matrigel. Note that AP20187 treatment caused no noticeable changes in acini size or morphology, consistent with the absence of modulation of P-
eIF2a levels in the same cells (A). (E) Confocal images showing Fv2E-DNPERK cells treated with (+AP) or without (-AP) AP20187 every 12 hrs stained
for LN-5 (green) to delineate the acini and active caspase-3 (red). Note that a majority of cells even in large acini can be pushed into apoptosis by
strong activation of PERK signaling. Scale bars=10 mm.
doi:10.1371/journal.pone.0000615.g007
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and also within the multi-acinar structures (Fig 9Ae, g, h and i,
arrows). This effect was not dependent on colony size as smaller
PERKDC colonies also showed stronger LN-5 staining within the
lumen-filled acini (Fig 9Ae). Western blots confirmed that LN5-c-
2 subunit (precursor and mature form) is upregulated in 2D cell
lysates of PERKDC expressing cells (Fig 9B). Further, as shown in
Fig 9C, culture in 3D over time yields more of the mature form of
LN-5 detected in the media of PERKDC vs. b-Gal cells. These
results suggest that increased LN-5 production, secretion and
deposition around and/or within the amorphous acini may
contribute to the strong IF signal. Our data shows that inhibition
of PERK can have important consequences on acinar homeostasis
as revealed by reduced GADD153 expression and increased
expression and enhanced deposition of LN-5.
Inhibition of PERK Signaling Results in Upregulation
of ErbB-1 and ErbB-2 and Tumor Formation in vivo
The large acinar structures developed by PERKDC expressing
MCF10A cells were to some extent similar to those generated by
activation of ErbB2 [2]. In addition, LN-5 is known to favor breast
carcinoma progression [45] and the expression of growth factor
receptors such as ErbB2 can be regulated at the translational level
[46]. Therefore we tested whether ErbB2 expression might be
upregulated in PERKDC vs. b-Gal cells. Western blot analysis
revealed that ErbB1 and ErbB2 were upregulated by 2.6 and 2.9
fold in PERKDC cells, respectively (Fig 10A). This suggests that
the aberrant behavior of PERKDC cells might in fact reflect
a transformed phenotype. Thus, we tested whether PERKDC cells
might have a proliferative advantage over b-Gal control cells in
vivo. MCF10A cells are non-tumorigenic in nude mice [47],
therefore we performed an orthotopic implantation of parental-,
b-gal- and PERKDC-MCF10A cells (3610
6) in the contra lateral
mammary fat pads of female nude mice that had the mouse
mammary epithelium removed. This was done anticipating that
the behavior and organization of MCF10A cells in vivo (single- vs.
multi-acinar structures) could be followed better in the mammary
tissue stroma without interference from the mouse mammary
epithelium. Efficiency of this technique was confirmed by histology
and revealed that a very small proportion of mouse ducts were
present after denuding the mammary fat pad (data not shown).
Follow up of these mice revealed no noticeable macroscopic
changes in the site of implantation of parental or b-Gal expressing
MCF10A cells (Fig 10B). In contrast, and to our surprise, ,40%
of mice (n=30, total of two independent experiments) implanted
with PERKDC expressing cells developed tumor nodules with
a variable latency of 7–10 weeks (Fig 10B). Injection of equal
amounts of PERKDC cells (n=20, total of two independent
experiments) in the s.c. mouse tissue in the region of the
abdominal mammary glands did not produce any tumor nodules
at the same times, highlighting the importance of an orthotopic
microenvironment (data not shown). Histopathological analysis
revealed that b-Gal control cells [47] did not survive in the
epithelium-denuded mammary fat pads, as they did in 3D
Matrigel cultures. No acini- or duct-like structures could be
observed and if any (few remnant from the fat pad clearing), they
did not express b-Galactosidase activity (Fig 10Ca and data not
shown). In striking contrast, MCF10A cells expressing PERKDC
were able to survive in the mammary fat pad for months after
inoculation (Fig 10B–C). Most importantly, they developed
tumors that revealed a histopathology resembling hyperplasia
accompanied by strong fibrosis with a mixture of epithelial,
stromal and inflammatory cells (Fig 10Cb–e). PERKDC expres-
Figure 8. GADD153 Upregulation During Acini Development in 3D
Cultures is PERK-dependent. (Aa and Ab) Representative confocal
images through the equatorial section of Day10 MCF10A acini depicts
strong GADD153-positive staining (red) in cells in the luminal space
(arrowheads) that also display condensed nuclei, co-stained with
CyQuant (green) as well as in some cases, in cells that localize to the
outer basal layer of cells (arrow) that do not have condensed nuclei.
(Ac-f) Representative images of GADD153 staining (red) in b-Gal (Ac and
Ae) and PERKDC (Ad and Af), cells on Day 8 in Matrigel. Scale
bars=10 mm. (B) Graph showing the distribution and median of
GADD153- positive acini/field; 21 fields adding up to a total of 215 acini
were scored.* P,0.001 determined by t test for independent samples.
doi:10.1371/journal.pone.0000615.g008
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organized acini- and duct-like structures (Fig 10Cb). In some
regions of the lesion an accumulation of epithelial cells along with
an inflammatory or fibrotic infiltrate without a defined epithelial
architecture was also evident (Fig 10Cb arrows and Cc).
Several acini-like structures showed a multi-layered arrangement
of epithelial cells characteristic of hyperplasia and in some cases
although lumen formation was evident (Fig 10Cd) we also found
structures where the lumen was either non-existent or filled by
epithelial cells (Fig 10Ce and insets). We next confirmed that
these cells expressed the PERKDC-Myc transgene by performing
IHC for anti-Myc (Fig 10Cg–i). b-Gal cells in 2D culture
displayed low background staining when using anti-Myc Abs that
was comparable to IgG background (Fig 10D). In contrast,
a strong whole-cell signal was observed for PERKDC cells grown
on 2D coverslips, fixed and stained with anti-Myc Abs (Fig 10D).
No staining was observed for IgG stained in the duct-like
structures of PERKDC tumors (Fig 10C–g). In contrast, the
acini-like structures in the area of the PERKDC lesion (Fig 10C–
b) were positive for Myc, confirming that these were derived from
MCF10A-PERKDC cells (Fig 10C–h–i). Only the stromal tissue
within the PERKDC lesions showed a somewhat stronger Myc
staining suggesting that MCF10A-PERKDC cells may possibly
have also populated the stromal fibrotic tissue or perhaps
undergone trans-differentiation [41] (Fig 10C–i). Alternatively,
it is possible that the anti-Myc antibody might cross-react to some
degree with mouse stromal cells as some cross reactivity with
mouse Myc has been reported for the 9E10 mAb [48]. However,
we detected no staining whatsoever in stromal or epithelial cells
from the few remnant normal mouse ducts away from the lesion
but in the same section (data not shown). We conclude that in vivo
expression of a truncated PERK dominant negative mutant
facilitates the development of tumor lesions comprising hyperpla-
sia and fibrosis.
Figure 9. PERK Inhibition Results in Increased Laminin-5 Production, Secretion and Deposition. (A) Confocal images showing the equatorial cross
sections through b-Gal (A-a, A-b and A-f) and PERKDC (A-c to A-e and A-g to A-i) acini stained for Laminin-5 (green), on Day 8 in 3D. Note the
increased staining and disorganized Laminin-5 deposition in PERKDC cells as compared to proper basal localization in the b-Gal control cells. Panels
A-e and A-g through A-i (arrows) show details of intra-acinar deposition of Laminin-5 within and around cells in the filled lumen. Scale bars=10 mm;
A-h is a magnified image of an acinus shown in A-g. (B) Western blot analysis from b-Gal and PERKDC cell lysates shows the precursor (P) and mature
(M) forms of LN-5. BimEL was used as loading control. (C) Western blot for Laminin-5 secreted into the conditioned media by b-Gal and PERKDC cells
grown in 3D-Matrigel. For conditioned media, samples corresponding to days 4 and 8, the supernatant was collected after 96 hrs of 3D culture. For
the conditioned media sample corresponding to day 10, the supernatant was collected after 48 hrs of 3D culture. DC=MCF10A-PERKDC cells. Note
that while in cell lysates (B) the precursor is predominantly detected, in the conditioned media there is stronger detection of the mature form of the
Laminin-5-c2 subunit.
doi:10.1371/journal.pone.0000615.g009
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Our results reveal two important and previously unrecognized
salient findings: the first is a link between adhesion signaling and
PERK-dependent phosphorylation of eIF2a; the second, is the
adhesion-dependent role of PERK in inhibiting proliferation and
tumor formation both in 3D in vitro and in vivo animal models,
respectively.
Early studies [8,49] showed that MEFs in suspension displayed
translational repression. More recent studies [50] showed that in
NIH3T3 fibroblasts, the suspension-induced translation repression
correlated with increased P-eIF2a levels. Our results are in
accordance with, and further extend these findings by showing
that loss of adhesion can regulate eIF2a phosphorylation in
a PERK-dependent manner. That PERK is responsible for eIF2a
phosphorylation, is supported by our results showing that PERK-/-
MEFs display reduced phosphorylation of eIF2a as compared to
wtPERK MEFs placed in suspension. Further, MCF10A cells
expressing dominant negative PERK mutants display reduced P-
Figure 10. PERK Inhibition in MCF10A Cells Favors Mammary Tumor Formation. (A) Western blot for ErbB1 (EGFR) and ErbB2 (Her2) levels in
adhered b-Gal or PERKDC cells show increased levels when PERK is inhibited. GAPDH was used as loading control. (B) b-Gal or PERKDC cells were
injected orthotopically into the contralateral abdominal mammary fat pads of 3 week-old female nude mice (see methods for details). Post-
implantation mice were monitored biweekly for tumor take and when detected tumor diameters were measured and the volume was calculated and
plotted as described in methods. Note that none of the mice implanted with b-Gal-MCF10A cells developed tumor nodules. (C) Histology of
mammary glands and tumors in mice implanted with b-Gal and PERKDC expressing MCF10A cells. (C-a) H&E staining of a cleared mammary fat pad
inoculated with b-Gal cells. Only adipose tissue and occasional stromal cells that were negative for b-galactosidase activity was observed. (C-b) H&E
staining of a PERKDC tumor lesion. Note the disorganization of the fibrotic-epithelial tissue. Arrows depict the presence of epithelial cells forming
acinar or duct-like structures within the PERKDC tumor lesion. (C-c) Higher magnification of intratumoral accumulations of cells without a defined
architecture but comprised of a mixture of epithelial (larger nuclei and pink cytoplasm) and inflammatory cells (smaller darkly stained nuclei). (C-d and
e) PERKDC cells form acini-like structures with an empty lumen or show hyperplastic growth and a repopulated lumen (C-e, top left and right insets).
(C-f) Anti-Myc (aMyc) staining in control b-Gal injected mammary fat pads. Note that only a light background signal is observed in adipocytes. (C-g)
Histological section of a PERKDC acinus-like structure stained with a non-specific IgG (arrow denotes the lack of staining in these epithelial cells) or
with anti-Myc 9E10 mAb (C-h and C-i); arrows denote the brown staining generated by Myc-tag detection. (D) b-Gal (left panel) or PERKDC (middle
and right panels) cells grown on 2D coverslips and fixed and stained with a non-specific IgG (IgG) or with an anti-Myc 9E10 mAb (a-Myc). The Myc
staining was characteristic of intracellular cistern distribution.
doi:10.1371/journal.pone.0000615.g010
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other eIF2a kinases, such as GCN2 and PKR are not affected in
suspension. Our results also show that higher levels of P-eIF2a and
ATF4 could be detected after blocking b1-integrin function,
suggesting that ligand-bound b1-integrin might prevent the
activation of PERK and downstream signaling. Further studies
are required to determine the exact mechanism of the crosstalk
between adhesion receptors and PERK. The inhibition of
translation in suspension may be due to the fact that phosphor-
ylation of eIF2a at Ser51 results in the sequestration of its GEF,
eIF2B preventing eIF2a-GTP hydrolysis [12]. While ATF4,
GADD153 and to a lesser extent XBP-1 were upregulated in
suspension, other genes commonly regulated during ER stress such
as BiP/Grp78, PDI/Erp72, HSP47 were not upregulated. This
suggests that suspension-induced stress activates a pathway that
only partially overlaps with the repertoire of genes activated, for
example, during the unfolded protein response [13].
Importantly, activation or inhibition of PERK-independent
pathways appeared to strongly regulate suspension-induced trans-
lational repression, as inhibition of PERK was not sufficient to
restore protein synthesis and prevent anoikis. Alternatively, this
could be due to residual eIF2a phosphorylation, since as little as
10% of eIF2a phosphorylation can cause a strong repression of
translation [12,22]. Another possibility maybe the fact that the
eIF4E pathway may still be inhibited in suspension [51,52]. It is
also possible that phosphorylation of PERK and eIF2a in
suspension may have other functions not immediately linked to
apoptosis (cleaved caspase-3 as a readout) but to other forms of cell
death [53]. Moreover, it was interesting to find that PERKDC
enhanced protein synthesis in adhered conditions and prevented
DTT-induced translational repression. This suggests that PERK
signaling may be required in the adherent cells to inhibit
proliferation and PERKDC-expressing cells might be refractory
to these signals during acinus formation. Perhaps, maintenance of
LN-5 expression at basal levels is required to prevent hyper-
proliferation as only PERKDC MCF10A cells were surrounded by
large LN-5 deposits and positive for Ki67 in the lumen-filled acini.
The signals that activate PERK during acinar morphogenesis are
unknown but it is possible that more subtle changes in adhesion or
in matrix composition that activate PERK may become evident as
the acinus reaches its terminal size [4].
Our results showed that the proliferative and tumor suppressive
effect of PERK and eIF2a signaling is not due to their ability to
induce anoikis in response to loss of adhesion, but due to the
inhibition of proliferation in adherent cells. The PERKDC-
induced stimulation of proliferation and tumor initiation was
unexpected and raises the question of the mechanisms behind this
phenomenon. The PERKDC-induced phenotype resembled,
although not as strongly, that of ErbB2 activation in MCF10A
cells [2,4]. Is it possible that activation of PERK suppresses
proliferation and tumorigenesis by inhibiting the rates of trans-
lation of proteins involved in growth factor signaling? Insight into
this question is provided from studies by Sonenberg and colleagues
[22] showing that expression of a dominant negative PKR (DN-
PKR) variant or of an eIF2a -Ser51Ala mutant in mouse NIH3T3
cells induced transformation. It was proposed that specific mRNAs
that are poorly translated when translation initiation is low or
normal become highly translated upon eIF2a dephosphorylation
[22]. Several growth factors (i.e. IGF, EGF, PDGF), tyrosine
kinases and transcription factors, that would be prone to such
regulation were shown to contain long highly structured 59-UTRs
that can inhibit binding of eIF4F or prevent ribosome scanning
[12,54]. In support of this hypothesis, our results show that in
PERKDC cells there is an upregulation of ErbB1 and ErbB2,
suggesting that this may be a source of proliferative signaling in
PERKDC cells. Finally, the upregulation of LN-5 in the PERKDC
multi-acinar structures may favor proliferation and survival of the
cells. LN-5, b1 and b4-integrin signaling have been shown to
promote proliferation, survival and aid in breast cancer pro-
gression [24,44] [45].
Although still unknown in our system, it is also possible that the
PERK-dependent post transcriptional regulation of cyclin D1
expression [17] may play a role suppressing proliferation and
tumorigenesis. In addition, it will be important to determine
whether knock down of GADD153 or ATF4 phenocopy the effects
of PERKDC and PERK-K618A mutants, as GADD153 at least
has been shown to have a growth suppressive function [15].
Furthermore, it will be crucial to determine when during acinar
morphogenesis PERK becomes activated and to what extent it
phosphorylates eIF2a. Then this level of activation can be
modeled using the Fv2E-PERK inducible system to determine
the effect of unscheduled activation of PERK at different stages
during this process.
Evidence from human mammary epithelial cells (HMECs)
transfected with various oncogenes also shows that inhibition of
eIF2a phosphorylation may be advantageous for tumor cells [55].
For example, as revealed in the Oncomine database HMEC cells
transfected with b-Catenin, c-Src, E2F3 and c-Myc show a down-
regulation of PERK at the transcript level [55]. Interestingly, c-Src
and b-Catenin, but not E2F3 and c-Myc transformed HMECs also
show a concomitant upregulation of GADD34 transcript, suggesting
that discrete oncogenic insults may take advantage of down-
regulating this growth suppressive pathway. Furthermore, estrogen
receptor negative but not positive tumors show downregulation and
upregulation of PERK and GADD34 transcripts, respectively
(p,0.001) [56]. Additional studies show an inverse correlation
between estrogen receptor status and GADD34 expression
[55,57,58]. These studies suggest that loss of regulation of eIF2a
phosphorylation may have consequences for breast cancer pro-
gression. Several rare autosomal-recessive mutations in PERK,
which cause deletion of the C-terminus or kinases of no or low
activityweredescribed inmembersofinbredfamiliesdiagnosed with
theWolcott-Rallisonsyndromethatdevelopdiabetes[59].However,
whether these occur sporadically in other tissues such as breast and
whether they have a role in cancer is unknown.
In support of a role for PERK functioning as an inhibitor of
tumor formation, PERKDC expressing MCF10A cells were able
to form benign lesions when implanted orthotopically in nude
mice. This suggests that PERK signaling may be important in
suppressing the early stages of tumor progression in the breast.
Interestingly, studies by Bi et al., [60] have shown that although
wild type and PERK-/-MEFs that are immortalized with SV40 T-
antigen and then transformed with an active Ras-V12 mutant
form tumors with similar incidence, those lacking PERK grow, but
at a slower rate [60]. A similar result was observed in HT29 colon
carcinoma cells expressing a PERKDC mutant [60]. Mechanistic
analysis revealed that this is in part due to in the inability of Ras-
transformed PERK-/-MEFs to survive hypoxia and signal to
mount an angiogenic response [60]. Our data support an anti-
proliferative role for PERK in normal mammary epithelial cells in
addition to the pro-survival function it might have in hypoxic
regions of Ras-induced fibroblastic tumors [60]. In agreement with
the latter we have also found in other model systems that PERK
has a pro-survival function [19]. It is possible that depending on
the context, like other molecules (e.g., Tiam1 [61] TGF-b [62]),
PERK signaling may have different functions during tumor
progression. It may operate as a tumor inhibitory pathway during
tumorinitiationbutinother casesitmaybeco-optedandbecomean
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stress[60].Thisfunctionhasalsobeenattributedtootherarmsofthe
UPR [63]. In support of the hypothesis that ER stress signals can be
tumor suppressive, recent findings showed that ATF6, ATF4 and
XBP-1 signaling can suppress H-Ras induced transformation in
melanocytes [21]. Further as mentioned before, eIF2a was found to
suppresstransformation,sinceNIH3T3 mouse fibroblastsexpressing
a Ser-51 to Ala mutant of eIF2a become transformed and
tumorigenic in vivo [22]. The effects of complete PERK inhibition
in normal mammary gland development are not known, since
PERK knockout mice display severe neonatal diabetes and die
shortly after birth [64]. Thus the generation of PERK conditional
knock out mice in the mammary gland epithelium will aid in
investigating the function of PERK in this tissue.
To conclude, our studies reveal that PERK activation and
possibly downstream eIF2a signaling is regulated by adhesion
through an as yet unknown mechanism. This signal appears to be
required to limit proliferation and allow for normal acinar
morphogenesis. Most importantly, this pathway appears to have
a tumor suppressive effect. It is possible that phosphorylation of
eIF2a and inhibition of proliferation is a rapid mechanism for
mammary epithelial cells to adapt to changes in the microenvi-
ronment (i.e. alterations in the stromal compartment, hormonal
regulation) or to systemic or environmental factors that could
cause damage and subsequent unscheduled or deregulated growth.
Thus, loss of PERK signaling might influence downstream genetic
and/or epigenetic changes favoring hyper-proliferative disorders
characteristic of early steps of breast cancer progression.
MATERIALS AND METHODS
Cell Culture and Materials
Low passage MCF10A cells were maintained as described
previously [39,47]. For 3D cultures, cells were plated on
commercially available matrix (growth-factor-reduced Matrigel
with protein concentrations between 9–12 mg/ml) from BD
Biosciences (San Diego, CA) and purified mouse laminin-1 was
obtained from Chemicon International (Temecula, CA). Primary
HMECs were obtained from Cambrex (East Rutherford, NJ) and
cultured according to manufacturers instructions. HEK293T cells
were maintained in DMEM supplemented with 10% FBS and100
U/ml penicillin/streptomycin. Wild type and PERK-/-mouse
embryo fibroblast cells (MEFs) were kindly provided by Dr. David
Ron (NYU) and maintained as described [14]. AP20187 was
obtained from ARIAD Pharmaceuticals, Cambridge, MA (www.
ariad.com/regulationkits).
Antibodies
Rabbit anti-phospho-PERK (16F8), anti-phospho-eIF2a (Ser 51),
anti total-eIF2a, anti-phospho and total PKR and GCN2, anti-
Bim and anti-cleaved caspase-3 were from Cell Signaling
(Danvers, MA). Anti-c-Myc, anti-E-cadherin and anti-GM130
were from BD Biosciences, rabbit anti-phospho-PERK (sc-32577-
R), anti-total PERK (H-300), anti-ATF4 and anti-GADD153 from
SantaCruz Biotechnology (Santa Cruz, CA) and Biolegend (San
Deigo, CA). Anti-Ki-67 from Invitrogen (Carlsbad, CA), anti-
GAPDH from Ambion (Austin, TX). Mouse anti-ESA (Clone
323/A3) was from Neomarkers (Fremont, CA). Function-blocking
AIIB2 supernatant and concentrate was obtained from De-
velopmental Study Hybridoma Bank (University of Iowa, Ames,
IA). Mouse and rabbit anti-IgG, CyQuant nuclear dye and Alexa
488 or 568 conjugated secondary antibodies were from Sigma (St.
Louis, MO) and Invitrogen respectively. HRP conjugated anti-
mouse IgG and mounting media were from Vector Laboratories
(Burlingame, CA) and Invitrogen respectively. Anti-laminin-5 and
HRP conjugated anti-rabbit IgG was from Chemicon (Temecula,
CA).
Retroviral Vectors and Stable Cell Lines
pBABEpuro-PERKDC (lacking the kinase domain of PERK) and
pBABE-Fv2E-PERK have been previously described [43]. The
Fv2E dimerization kit was from Ariad Pharmaceuticals (www.
ariad.com/regulationkits). The myc-tagged PERK-(K618A) mu-
tant construct was obtained from J. Alan Diehl (UPenn, PA) and
cloned into a pBABEneo retroviral vector. Retroviral vectors were
transfected in the Phoenix Ampho retroviral packaging cell line,
maintained in DMEM supplemented with 10% FBS and 100U/
ml penicillin/streptomycin. All stable cell lines were generated by
retroviral infection of MCF10A cells followed by treatment with
2.5 mg/ml puromycin or 400 mg/ml neomycin selection. Stable
MCF10A cells expressing the Fv2E-PERK fusion protein were
generated, where the kinase domain of PERK is fused to the
modified FKBP (Fv) domain, and is activated through dimeriza-
tion with the bivalent ligand AP20187 in nanomolar concentra-
tions. A pBABEpuro-bGalactosidase construct expressing b-
Galactosidase served as vector control.
Anoikis Assays
Tissue culture plates were coated with sterile 1% agar dissolved in
PBS and allowed to solidify before use. MCF10A, primary
HMECs, and HEK293T cells were placed in the appropriate
growth medium containing serum, in the presence of 0.5%
methylcellulose (to avoid clumping of cells) in suspension and
plated on agar-coated dishes in a humidified 37uC incubator. For
Fv2E-PERK stable cell lines, cells were treated with 2nM of
AP20187 (added fresh daily) or equal volume of EtOH as control.
Integrin function blocking antibody experiments were carried as
follows: Laminin-I (10 mg/ml) in PBS was coated on plates
overnight at 37uC, washed with PBS and blocked with 0.1mg/ml
BSA at 37uC for 1 h. For suspension, cells were plated on 1% agar
in 0.5% methylcellulose as above. MCF10A cells were detached
with 2mM EDTA in PBS, resuspended in serum-free DMEM:F12
and equal numbers of cells (1–2.5610
6) were pre-incubated with
10 mg/ml AIIB2 or 10 mg/ml control IgG for 30 min at 37uC,
prior to plating in media containing 1% serum with all
supplements for an additional 24h.
Immunoblotting
Cells from either adhered or suspended cultures were washed with ice
cold PBS, lysed with RIPA buffer containing protease and
phosphatase inhibitors and processed for immunoblot analysis as
described previously [19]. For detection of phospho- and total PERK
in MCF10A cells, 100 mM b-glycerophosphate was added to cells
30 min prior to lysis in an attempt to preserve PERK phosphory-
lation. Adhered or suspended cells were washed with ice cold PBS
followed by PBS-EDTA, and lysed on ice with Lysis buffer containing
1% Triton-X-100, 150 mM NaCl, 20 mM Hepes, 10% glycerol, and
1 mM EDTA. Sodium orthovanadate (1 mM), 100 mM NaF and
17.5 mM b-glycerophosphate, 1mM PMSF, 4 mg/ml Aprotinin and
2 mg/ml Pepstatin A were added freshly before use [14]. 20 mgo f
total protein was separated on a 6% SDS polyacrylamide gel. PERK
antibodies were used at a dilution of 1:200.
RT-PCR Analysis
ATF4, GADD153, XBP-1, BiP, HSP47 and PDI/Erp72 mRNA
was analyzed using 1-2 mg of total RNA isolated from MCF10A,
or HEK293T cells (Trizol reagent, Invitrogen) grown adhered or
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RT-PCR kit from Ambion according to manufacturer’s instruc-
tions. GAPDH was used as loading control. Primer sequences used
were: GADD153 (F) 59-GGAAGCCTGGTATGA-GGACC;
GADD153 (R) 39-CCAATTGTTCATGCTTGGTG, ATF4 (F)
59-TCAAACTTCA-TGGGTTCTCC-39; ATF4(R) 59-GTGTC-
ATCCAACGTGGTCGTCAG-39, XBP-1 (F) 59-CCTTGT-
AGTTGAGAACCAGG-39; XBP-1 (R) 59-GGGGCTTGGTA-
TATATGTGG-39, BiP (F) 59-GGGTGGCGGAACCTTCGA-
TGTGTC-39; BiP (R) 59-ATTTGGCCCGAGTCA-GGGTCT-
CAG-39, Hsp47 (F) 59-TGCAGTCCATCAACGAGTGGGC-
CG-39; Hsp47 (R) 59-TCGTCGTCGTAGTAGTTGTAGAG-
GC-39, PDI/Erp72 (F) 59-CAATACCAGGATGCC-GCTAA-
CAACC-39; PDI/Erp72 (R) 59-GCATCGTTTGACACCTTGC-
GGTGG-39 and GAPDH (F) 59-CGTCATGGGTGTGAAC-
CATGAG-39; GAPDH (R) 59-GTAGACGGCAGGTC-AGGT-
CCA-39.
Transient cDNA Transfections
Cells were transiently transfected using FuGene
TM transfection
reagent (Roche) with a pGADD153-EGFP reporter (a gift from
Dr. S. Howell, UCSD) alone or with a pFLAG-CMV-2-GADD34
or a pcDNA3.1Hygro plasmid. 24 h post-transfection, cells were
either left adhered or detached by mild trypsinization and put into
suspension on 1% agar coated tissue culture plates with 0.5%
methylcellulose for an additional 24 or 48 hours, and analyzed by
flow cytometry as described [19].
FACS Analysis
GFP fluorescence was quantitated using Epics ALTRA (Beck-
mann Coulter) or LSRII (BD Pharmingen) flow cytometers as
described [19]. For anoikis assays, 10,000 events were collected
and the percentage of apoptotic cells in adhered or suspension
cultures was detected using propidium iodide staining (BD
Pharmingen). The sub-G0 cell population was gated as the
apoptotic fraction. Unstained cells served as negative control.
Metabolic Labeling and Polysome Gradients
To measure protein synthesis, 0.5610
6 MCF10A cells were seeded
in 60 mm dishes both in adhered or in suspension conditions as
described above. 24 hrs later the cells were washed twice with PBS
and incubated with methionine/cysteine- free DMEM:F12 media
containing 10% HS for 1h. Cells were then pulse-labeled for
30 min with medium containing 50 mCi/mL of Redivue Pro-mix
L-[
35S] cell labeling mix (GE Healthcare, Piscataway, NJ) and
lysed as described [19]. 5 ml of lysate/lane was loaded onto a 10%
gel and analyzed by Coomassie staining for protein loading and by
autoradiography for the detection of
35S-methionine incorpora-
tion. For polysome gradient analysis MCF10A cells (6610
6 cells/
15 cm plate) were plated at 50% confluence in adhered or
suspension conditions 24 hrs before analysis and analyzed as
described previously [14].
Mice and Transplantation of Cleared Mammary Fat
Pads
Female FVB nude mice were anesthetized with ketamine, given
i.p. in a mixture containing 1 ml ketamine, 1 ml xylazine and
4.2 ml sterile saline (dose of 0.1 ml/30 g body weight) for 40–
45 min. The abdominal (4
th) mammary glands of 3-week-old
female mice were cleared of endogenous epithelium by surgical
excision just distal of the mammary lymph node, a positional
landmark. On day 0, b-Gal control or PERKDC-expressing
MCF10A cells were suspended in serum free media in a 50-ml
volume (3610
6 cells/mouse) and injected in the cleared fat pad
using a 25 gauge needle to avoid damaging the cells. Mice were
injected with xylazine for two days post-surgery. Mammary glands
were palpated twice a week to detect any growth at the inoculation
sites. Tumor volume in the PERKDC-transplanted mammary fat
pads was measured using calipers and calculated according to the
following equation: (Length6width
2)/2=tumor volume (mm
3).
The glands with or without tumors were dissected and processed
for sectioning or stained with hematoxylin-eosin. Briefly, mounted
glands were left for 2–3 mins at RT to adhere to glass slides, then
transferred to 10% formalin (Sigma) and fixed overnight at 4uC.
The next day, samples were washed twice with 70% ethanol,
detached from the slides, placed between sponges inside histology
cassettes submerged in 70% ethanol and sent to the Histology
Core facility (MSSM, NY) to be dehydrated and processed for
paraffin embedment. All animal protocols were approved by the
IACUC committee, MSSM, NY and SUNY-Albany, NY.
Immunohistochemistry for c-Myc Expression
Sections from control b-Gal or PERKDC transplanted mammary
fat pads were fixed and processed for c-Myc staining. Briefly,
tissues were deparaffinized in xylene followed by three washes in
a graded series of ethanol, then permeabilized for 10 minutes in
0.5% Triton-X 100. Slides were rinsed with PBS, dehydrated in
a graded series of ethanol, and dipped in 3% hydrogen peroxide
and methanol for 20 minutes to block endogenous peroxidase.
Slides were then rehydrated, blocked for 1 hr in PBS plus normal
goat serum, following vendor instructions (Vector Laboratories,
Vectastain Elite ABC Kit) and incubated for 10 minutes at room
temperature with either an anti-C-myc antibody (BD Biosciences)
or a control IgG (Sigma). Slides were incubated with a biotinylated
secondary antibody (Vectastain Elite ABC Kit) for 1 hour at RT
and antibody binding was detected with the Vectastain ABC Kit
as indicated by the vendor. The peroxidase activity was developed
by diaminobenzidine and nuclei were counterstained with
Hematoxilin.
Immunofluorescence and Confocal Microscopy
Briefly, for detection of GADD153 and ATF4 in adherent vs.
suspended cells these were either grown on glass coverslips
(adherent) or collected by centrifugation from suspension cultures
and allowed to attach to polylysine-coated coverslips for 30 min
and fixed with 3% paraformaldehyde and stained following
standard protocols [19]. Images were captured using a Nikon
Eclipse TS100 epifluorescence microscope fitted with a digital
SPOT-RT camera. The protocol for indirect IF of MCF10A cells
in 3D has been previously described [39]. Confocal images were
acquired by using a Leica TCS SP5 inverted confocal microscope
(Leica Microsystems, USA) with a 406objective or with a LSM5
Meta (Zeiss) with 256objectives. Raw images were visualized and
analyzed using Adobe Photoshop 6.0, SPOT and ImageJ software.
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